Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis

Lin Zhang; Lihong Mao; Junxiu Xu

doi:10.18632/oncotarget.6289

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis

Lin Zhang _, Lihong Mao and Junxiu Xu

PDF | HTML | How to cite

Oncotarget. 2016; 7:2455-2461. https://doi.org/10.18632/oncotarget.6289

Metrics: PDF 1382 views | HTML 1489 views | ?

Abstract

Lin Zhang1, Lihong Mao1 and Junxiu Xu1

1 Department of Clinical Laboratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Correspondence to:

Lin Zhang, email:

Keywords: graft-versus-host disease, TGF-β1, meta-analysis, genetic

Received: July 20, 2015 Accepted: October 04, 2015 Published: November 03, 2015

Abstract

Some studies have demonstrated that transforming growth factor (TGF)-β polymorphisms may have an important role in the pathological process of graft-versus-host disease (GVHD). However, the results are not consistent. Thus, we performed a meta-analysis. Online databases were searched to obtain relevant articles published up until May 2015. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Donors (OR=0.56; 95%CI, 0.32–0.98; P=0.04) and recipients (OR=0.73; 95%CI, 0.63–0.85; P<0.0001) with TGF-β1 rs1800469 polymorphism showed decreased GVHD risk, respectively. Donors with TGF-β1 rs1800470 polymorphism were also observed to have lower GVHD risk (OR=0.65; 95%CI, 0.46–0.94; P=0.02). However, TGF-β1 rs1800470 polymorphism in recipients was not associated with GVHD risk (OR=1.28; 95%CI, 0.81–2.01; P=0.29). No significant heterogeneity was found in the meta-analysis. This meta-analysis suggests that donors or recipients with TGF-β1 rs1800469 polymorphism and donors with TGF-β1 rs1800470 polymorphism might be associated with reduced GVHD risk.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6289

Publication Alerts

Research Papers:

Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis

Abstract